Mirum Pharmaceuticals Cash Flow Statement (2019-2026) | MIRM

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-43.89M-47.11M57.28M-36.61M-26.92M-35.71M-36.43M-30.13M-74.04M-23.59M-35.66M-25.28M-24.64M-14.23M-23.79M-14.68M-5.86M2.90M-5.73M-790.15M
Share-based Compensation (Quarter)
4.82M7.42M-17.42M6.56M0.20M0.20M27.01M8.56M0.20M8.38M9.72M11.45M11.84M-13.65M38.81M15.80M18.47M18.13M19.03M4.47M
Cash from Operations (Quarter)
-40.20M-34.20M-33.15M-39.67M-20.17M-26.02M-34.27M-18.77M-17.33M-18.22M-16.62M15.21M-3.80M3.98M-5.07M-1.96M12.04M39.68M6.07M-228.76M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.03M0.06M0.06M0.04M0.06M0.58M1.02M0.83M0.63M0.23M0.03M
Amortization of Deferred Charges (Quarter)
0.10M0.09M-0.28M0.10M-0.10M0.31M0.41M0.40M0.41M0.41M0.42M0.42M0.43M0.43M0.44M0.44M0.45M
Depreciation & Amortization (CF) (Quarter)
0.08M0.08M0.34M0.34M0.60M1.10M1.20M1.34M1.34M2.66M5.49M5.66M5.85M6.05M6.06M6.05M6.06M6.06M6.07M6.87M
Change in Working Capital
Change in Receivables (Quarter)
4.61M6.12M2.35M7.66M0.67M10.66M12.51M20.13M-12.97M5.43M8.10M10.86M16.83M9.07M3.15M19.01M12.89M
Change in Inventory (Quarter)
0.49M0.07M1.18M2.80M-0.60M0.78M0.99M0.44M-1.23M0.96M1.08M0.90M0.21M2.67M2.33M1.16M2.28M1.92M
Change in Accured Expenses (Quarter)
-7.37M3.78M9.02M-8.07M8.89M6.83M-0.01M-1.21M9.18M10.29M12.53M11.28M6.94M12.75M9.34M11.74M10.58M24.35M3.44M57.24M
Other Working Capital Changes (Quarter)
-0.21M2.34M1.77M0.64M-0.36M0.16M-0.31M-0.28M0.06M3.68M-2.94M-0.01M0.10M1.03M0.38M3.03M4.08M-3.09M1.64M4.80M
Investing Activities
Capital Expenditures (Quarter)
0.02M0.00M0.02M0.02M0.24M0.04M0.07M0.01M0.78M0.18M0.02M0.04M0.13M0.19M0.60M0.66M
Change in Acquisitions & Divestments (Quarter)
21.50M47.50M38.00M36.50M38.80M38.00M27.00M64.50M55.50M30.00M3.00M7.75M12.14M17.43M25.06M18.82M13.11M33.89M
Cash from Investing Activities (Quarter)
-24.45M-2.24M108.02M36.50M23.97M-79.53M26.76M27.02M50.55M-182.76M-2.00M-0.01M-72.72M-18.04M0.64M-16.13M-6.60M-2.23M1.01M-11.57M
Financing Activities
Other financing activities (Quarter)
-4.82M17.38M-13.47M-7.44M-2.03M-2.88M6.37M198.88M-0.16M1.21M7.29M3.86M5.34M6.36M8.69M16.10M-31.14M259.95M
Cash from Financing Activities (Quarter)
65.91M0.34M0.61M18.10M5.25M86.07M-0.33M12.99M114.71M207.13M1.78M1.21M7.29M3.86M5.34M6.36M8.69M16.10M9.00M270.08M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
27.60M27.60M14.48M
Additional items
Exchange Rate Effect (Quarter)
0.00M0.01M-0.00M-0.05M-0.02M0.09M0.19M-0.11M-0.32M0.11M0.11M-0.12M0.09M-1.38M1.05M2.23M0.35M-0.41M-1.27M
Change in Cash (Quarter)
1.26M-36.09M75.50M14.93M9.00M-19.51M-7.76M21.42M147.81M5.83M-16.73M16.52M-69.35M-10.10M-0.47M-10.68M16.36M53.90M15.66M28.48M
Free Cash Flow (Quarter)
-40.20M-34.22M-33.15M-39.67M-20.19M-26.04M-34.51M-18.82M-17.40M-18.22M-16.62M15.20M-4.58M3.80M-5.09M-2.00M11.91M39.49M5.47M-229.43M
Net Cash Flow (Quarter)
1.26M-36.09M75.49M14.94M9.04M-19.49M-7.84M21.23M147.92M6.15M-16.84M16.40M-69.23M-10.19M0.91M-11.74M14.13M53.55M16.07M29.75M